WebDec 20, 2024 · ROCKIES is a Phase III, randomised, open-label, active-controlled trial designed to assess the efficacy and safety of roxadustat vs. epoetin alfa, for the treatment of patients with anaemia in CKD who are dialysis dependent. 2 The trial met its primary efficacy endpoint by demonstrating a statistically-significant improvement in mean … WebSep 1, 2024 · The results of this trial indicate that a restrictive PRBC transfusion strategy (transfusion for Hgb ≤8 g/dl, goal 8-10 g/dl) is noninferior to a more liberal strategy …
Higher or Lower Hemoglobin Transfusion Thresholds for Preterm …
WebNov 17, 2024 · Erythroid Response is defined as an increase from baseline ≥1.0 g/dL in mean of hemoglobin values over a continuous 12-week interval from Weeks 37 to 48 of … WebAug 25, 2024 · What Is New? Vericiguat, compared with placebo, reduces the risk of in patients with heart failure with a reduced ejection fraction in the VICTORIA trial (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction); patients on vericiguat were noted to have a higher incidence of anemia and a modestly lower … lake front storage sandia tx
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
WebSep 1, 2024 · The results of this trial indicate that a restrictive PRBC transfusion strategy (transfusion for Hgb ≤8 g/dl, goal 8-10 g/dl) is noninferior to a more liberal strategy (transfusion for Hgb ≤10 g/dl, goal Hgb >11 g/dl) at 30 days. In addition, infections and acute lung injury were higher with a more liberal strategy. WebPatients. From July 19, 2004, through February 28, 2009, we enrolled patients at 47 clinical sites in the United States and Canada. Telephone follow-up ended on May 4, 2009. WebDec 4, 2024 · The target hemoglobin range for LR-MDS patients is 10 to 12 g/dL with ESA treatment or to achieve an increase in hemoglobin level by ≥1.5 g/dL or a decrease in … helidon shops